Seres Therapeutics
Price & Volume
Stats
See moreOpen | $19.60 |
Previous Close | $19.50 |
Day Range | $18.56-$19.85 |
52W Range | $6.53-$24.66 |
Market Cap | $171.9M |
Shares Short | 936,245 |
Financials
See moreRevenue (12 Mos) | $126.3M |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | -$9.2M |
Diluted EPS | -$6.79 |
News
See moreYahoo Finance • 17 days ago
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
Yahoo Finance • 29 days ago
QuantumScape rallies as Seeking Alpha analyst pitches the upside
Yahoo Finance • last month
Rapport Therapeutics prices $250M stock at $26 per share
Yahoo Finance • last month
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum
About
CEO | Mr. Thomas J. DesRosier Esq., J.D. |
CFO | Ms. Marella Thorell CPA |
Address | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
